[1]
|
Ross, R. (1999) Atherosclerosis—An Inflammatory Disease. The New England Journal of Medicine, 340, 115-126.
https://doi.org/10.1056/NEJM199901143400207
|
[2]
|
Libby, P., Ridker, P.M. and Hansson, G.K. (2011) Progress and Challenges in Translating the Biology of Atherosclerosis. Nature, 473, 317-325. https://doi.org/10.1038/nature10146
|
[3]
|
Donoghue, M., Hsieh, F., Baronas, E., et al. (2000) A Novel Angiotensin-Converting Enzyme-Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9. Circulation Research, 87, E1-E9.
https://doi.org/10.1161/01.RES.87.5.e1
|
[4]
|
Zhong, J.C., Guo, D., Chen, C.B., et al. (2011) Prevention of Angiotensin II-Mediated Renal Oxidative Stress, Inflammation and Fibrosis by Angiotensin-Converting Enzyme 2. Hypertension, 57, 314-322.
https://doi.org/10.1161/HYPERTENSIONAHA.110.164244
|
[5]
|
Tesanovic, S., Vinh, A., Gaspari, T.A., et al. (2010) Vasoprotective and Atheroprotective Effects of Angiotensin (1-7) in Apolipoprote in E-Deficient Mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 1606-1613.
https://doi.org/10.1161/ATVBAHA.110.204453
|
[6]
|
Thomas, M.C., Pickering, R.J., Tsorotes, D., et al. (2010) Genetic Ace2 Deficiency Accentuates Vascular Inflammation and Atherosclerosis in the ApoE Knockout Mouse. Circulation Research, 107, 888-897.
https://doi.org/10.1161/CIRCRESAHA.110.219279
|
[7]
|
Gaddam, R.R., Chambers, S. and Bhatia, M. (2014) ACE and ACE2 in Inflammation: A Tale of Two Enzymes. Inflammation & Allergy Drug Targets, 13, 224-234. https://doi.org/10.2174/1871528113666140713164506
|
[8]
|
Zhu, Y.H., Xian, X.M., Wang, Z.Z., et al. (2018) Research Progress on the Relationship between Atherosclerosis and Inflammation. Biomolecules, 8, Article No. 80. https://doi.org/10.3390/biom8030080
|
[9]
|
Badimon, L., Peña, E., Arderiu, G., et al. (2018) C-Reactive Protein in Atherothrombosis and Angiogenesis. Frontiers in Immunology, 9, Article No. 430. https://doi.org/10.3389/fimmu.2018.00430
|
[10]
|
Li, Y.W., Zhong, X.M., Cheng, G.C., et al. (2017) Hs-CRP and All-Cause, Cardiovascular, and Cancermortality Risk: A Meta-Analysis. Atherosclerosis, 259, 75-82. https://doi.org/10.1016/j.atherosclerosis.2017.02.003
|
[11]
|
Held, C., White, H.D., Stewart, R.A.H., et al. (2017) Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. Journal of the American Heart Association, 6, e005077.
https://doi.org/10.1161/JAHA.116.005077
|
[12]
|
Green, D., Foiles, N., Chan, C.L., et al. (2010) An Association between Clotting Factor VII and Carotid Intima-Media Thickness: The CARDIA Study. Stroke, 41, 1417-1422. https://doi.org/10.1161/STROKEAHA.110.580100
|
[13]
|
Fotis, L., Agrogiannis, G., Vlachos Ioannis, S., et al. (2012) Intercellular Adhesion Molecule (ICAM)-1 and Vascular Cell Adhesion Molecule (VCAM)-1 at the Early Stages of Atherosclerosis in a Rat Model. In Vivo, 26, 243-250.
|
[14]
|
Konstantino, Y., Nguyen, T.T., Wolk, R., et al. (2009) Potential Implications of Matrix Metalloproteinase-9 in Assessment and Treatment of Coronary Artery Disease. Biomarkers, 14, 118-129.
https://doi.org/10.1080/13547500902765140
|
[15]
|
Sriramula, S., Cardinale, J.P., Lazartigues, E., et al. (2011) ACE2 Overexpression in the Paraventricular Nucleus Attenuates Angiotensin II-Induced Hypertension. Cardiovascular Research, 92, 401-408.
https://doi.org/10.1093/cvr/cvr242
|
[16]
|
Jin, H.Y., Song, B., Oudit, G.Y., et al. (2012) ACE2 Deficiency Enhances Angiotensin II-Mediated Aortic Profilin-1 Expression, Inflammation and Peroxynitrite Production. PLoS ONE, 7, e38502.
https://doi.org/10.1371/journal.pone.0038502
|
[17]
|
Sahara, M., Ikutomi, M., Morita, T., et al. (2014) Deletion of Angiotensin-Converting Enzyme 2 Promotes the Development of Atherosclerosis and Arterial Neointima Formation. Cardiovascular Research, 101, 236-246.
https://doi.org/10.1093/cvr/cvt245
|
[18]
|
Mehta, P.K. and Griendling, K.K. (2006) Angiotensin II Cell Signaling: Physiological and Pathological Effects in the Cardiovascular System. American Journal of Physiology. Cell Physiology, 292, C82-C97.
https://doi.org/10.1152/ajpcell.00287.2006
|
[19]
|
Song, B., Jin, H.Y., Yu, X., et al. (2013) Angiotensin-Converting Enzyme 2 Attenuates Oxidative Stress and VSMC Proliferation via the JAK2/STAT3/SOCS3 and Profilin-1/MAPK Signaling Pathways. Regulatory Peptides, 185, 44-51. https://doi.org/10.1016/j.regpep.2013.06.007
|
[20]
|
Song, J.T., Qu, H.Y., Hu, B., et al. (2020) Physiological Cyclic Stretch Up-Regulates Angiotensin-Converting Enzyme 2 Expression to Reduce Proliferation and Migration of Vascular Smooth Muscle Cells. Bioscience Reports, 40, BSR20192012. https://doi.org/10.1042/BSR20192012
|
[21]
|
Schroeder, A.P. and Falk, E. (1995) Vulnerable and Dangerous Coronary Plaques. Atherosclerosis, 118, S141-S149.
https://doi.org/10.1016/0021-9150(95)90081-0
|
[22]
|
Fraga-Silva, R.A., Savergnini, S.Q., Montecucco, F., et al. (2014) Treatment with Angiotensin-(1-7) Reduces Inflammation in Carotid Atherosclerotic Plaques. Thrombosis and Haemostasis, 111, 736-747.
https://doi.org/10.1160/TH13-06-0448
|
[23]
|
Lovren, F., Pan, Y., Quan, A., et al. (2008) Angiotensin Converting Enzyme-2 Confers Endothelial Protection and Attenuates Atherosclerosis. American Journal of Physiology: Heart and Circulatory Physiology, 295, H1377-H1384.
https://doi.org/10.1152/ajpheart.00331.2008
|
[24]
|
Zhang, C., Zhao, Y.X., Zhang, Y.H., et al. (2010) Angiotensin-Converting Enzyme 2 Attenuates Atherosclerotic Lesions by Targeting Vascular Cells. Proceedings of the National Academy of Sciences of the United States of America, 107, 15886-15891. https://doi.org/10.1073/pnas.1001253107
|
[25]
|
Lin, Y.J., Zeng, H.S., Gao, L., et al. (2017) Hydrogen Sulfide Attenuates Atherosclerosis in a Partially Ligated Carotid Artery Mouse Model via Regulating Angiotensin Converting Enzyme 2 Expression. Frontiers in Physiology, 8, Article No. 782. https://doi.org/10.3389/fphys.2017.00782
|
[26]
|
Yang, J.M., Yang, X.Y., Meng, X., et al. (2015) Endogenous Activated Angiotensin-(1-7) Plays a Protective Effect against Atherosclerotic Plaques Unstability in High Fat Diet Fed ApoE Knockout Mice. International Journal of Cardiology, 184, 645-652. https://doi.org/10.1016/j.ijcard.2015.03.059
|
[27]
|
Zhang, Y.H., Zhang, Y.H., Dong, X.F., et al. (2015) ACE2 and Ang-(1-7) Protect Endothelial Cell Function and Prevent Early Atherosclerosis by Inhibiting Inflammatory Response. Inflammation Research, 64, 253-260.
https://doi.org/10.1007/s00011-015-0805-1
|